Hospital
Jamaica Hospital
Jamaica Hospital was paid $178.14M by Medicaid between Jan 2018 and Dec 2024, across 518 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 18% of everything it billed.
33Billing provider infoJAMAICA HOSPITAL
RICHMOND HILL, NY 11418
RICHMOND HILL, NY 11418
33aNPI1245370717assigned 02/07/2007
33bProvider typeGeneral Acute Care Hospital
28Total paid$178.14M
24GClaims3,580,920
24DCodes billed518
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in New York
Rank by total paid#7 of 231
Median peer was paid$561K
This provider vs. median318×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 32,977 | $1.34M | |
| 2019 | 289,383 | $9.84M | |
| 2020 | 606,914 | $22.18M | |
| 2021 | 714,383 | $28.75M | |
| 2022 | 627,065 | $48.29M | |
| 2023 | 721,668 | $41.55M | |
| 2024incomplete | 588,530 | $26.18M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 18% | 257,044 | 219,177 | $32.10M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 8.9% | 79,180 | 71,947 | $15.83M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 6.2% | 45,003 | 42,243 | $10.99M |
| 36415 | Collection of venous blood by venipuncture | 4.6% | 433,027 | 195,238 | $8.16M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4.4% | 56,450 | 52,209 | $7.81M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 4.2% | 77,916 | 69,890 | $7.44M |
| 90791 | Psychiatric diagnostic evaluationPsychiatric diagnostic evaluation | 3.9% | 8,083 | 7,212 | $7.01M |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 3.4% | 47,832 | 20,735 | $6.09M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 2.8% | 28,530 | 27,055 | $5.04M |
| G0378 | Hospital observation service, per hour | 2.0% | 3,146 | 2,995 | $3.58M |
| 80053 | Comprehensive metabolic panel | 1.8% | 150,300 | 78,125 | $3.23M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.8% | 26,792 | 23,986 | $3.20M |
506 more codes
| 96361 | Intravenous infusion, hydration; each additional hour | 1.7% | 18,759 | $2.96M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1.4% | 68,247 | $2.52M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.4% | 23,704 | $2.49M |
| S9485 | Crisis intervention mental health services, per diem | 1.2% | 1,833 | $2.19M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.2% | 21,934 | $2.11M |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1.2% | 18,219 | $2.06M |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 1.1% | 15,822 | $1.90M |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.0% | 17,833 | $1.78M |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 10,943 | $1.49M |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 11,705 | $1.34M |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 1,398 | $1.30M |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 16,435 | $1.24M |
| 92551 | <1% | 37,640 | $1.20M | |
| 80050 | General health panel | <1% | 52,159 | $1.14M |
| 99285 | Emergency room visit (most serious) | <1% | 5,703 | $1.12M |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 5,533 | $960K |
| 90461 | <1% | 24,252 | $948K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 6,850 | $938K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 9,434 | $905K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 41,002 | $898K |
| 99051 | <1% | 39,847 | $878K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 13,363 | $832K |
| 86481 | <1% | 17,046 | $806K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 3,021 | $762K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 5,376 | $761K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 5,245 | $750K |
| 81025 | <1% | 47,919 | $742K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 901 | $704K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 3,250 | $663K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 28,541 | $616K |
| 81514 | <1% | 2,830 | $610K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 6,227 | $600K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 17,984 | $596K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 35,873 | $550K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 28,094 | $540K |
| 99173 | <1% | 36,268 | $519K | |
| 90651 | <1% | 9,971 | $488K | |
| 90686 | <1% | 49,237 | $485K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 6,960 | $469K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 21,413 | $435K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 3,868 | $432K |
| 93970 | <1% | 2,321 | $425K | |
| 86850 | <1% | 14,646 | $418K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 609 | $391K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 27,632 | $389K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 37,048 | $389K |
| 80061 | Lipid panel | <1% | 57,416 | $386K |
| T1013 | Sign language or oral interpretive services, per 15 minutes | <1% | 27,347 | $383K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 5,867 | $379K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 969 | $344K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 2,167 | $336K |
| 76818 | <1% | 3,922 | $321K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 1,808 | $311K |
| 12001 | <1% | 1,077 | $308K | |
| 83655 | <1% | 22,283 | $307K | |
| 76830 | Ultrasound, transvaginal | <1% | 4,404 | $293K |
| 90715 | <1% | 13,265 | $292K | |
| 97163 | <1% | 2,153 | $290K | |
| 76801 | <1% | 3,687 | $286K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 2,078 | $281K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 6,273 | $277K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 2,527 | $272K |
| 90677 | <1% | 3,173 | $265K | |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | <1% | 249 | $264K |
| 88142 | <1% | 11,036 | $256K | |
| H2011 | Crisis intervention service, per 15 minutes | <1% | 3,337 | $247K |
| 97802 | <1% | 5,473 | $241K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 11,916 | $234K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 1,985 | $231K |
| 12011 | <1% | 841 | $227K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 54,182 | $213K |
| 96367 | <1% | 2,516 | $206K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 11,015 | $204K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 1,144 | $201K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 240 | $199K |
| 86901 | <1% | 14,652 | $197K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 6,414 | $188K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 2,676 | $187K |
| 99385 | <1% | 1,725 | $186K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 5,142 | $177K |
| 97010 | <1% | 12,014 | $177K | |
| 0002A | <1% | 4,725 | $176K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 3,799 | $169K |
| 86769 | <1% | 5,463 | $169K | |
| 97803 | <1% | 4,513 | $168K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 236 | $164K |
| 90732 | <1% | 1,587 | $162K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 3,364 | $160K |
| 0001A | <1% | 4,850 | $159K | |
| 86900 | <1% | 14,654 | $159K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 83,162 | $156K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 838 | $156K |
| 36416 | <1% | 4,616 | $152K | |
| 77065 | Tomosynthesis, mammo | <1% | 1,412 | $150K |
| 86003 | <1% | 4,752 | $150K | |
| 94060 | <1% | 1,390 | $147K | |
| 76770 | <1% | 947 | $145K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 1,901 | $137K |
| A0429 | Emergency ambulance ride, basic life support | <1% | 1,725 | $137K |
| 90670 | <1% | 12,735 | $136K | |
| 81003 | <1% | 33,261 | $134K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 861 | $132K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 930 | $131K |
| 76642 | <1% | 2,277 | $129K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 14,036 | $124K |
| 76536 | <1% | 1,440 | $121K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 7,146 | $119K |
| 86780 | <1% | 28,059 | $118K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 5,263 | $116K |
| 87088 | <1% | 19,340 | $111K | |
| 93971 | <1% | 1,675 | $108K | |
| 76820 | <1% | 3,045 | $107K | |
| 70486 | <1% | 2,189 | $103K | |
| 81001 | <1% | 49,715 | $102K | |
| 71250 | <1% | 1,034 | $101K | |
| 99397 | <1% | 1,267 | $99K | |
| 99386 | <1% | 895 | $97K | |
| 94726 | <1% | 1,127 | $96K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 2,351 | $94K |
| 77066 | Tomosynthesis, mammo | <1% | 844 | $94K |
| 12002 | <1% | 326 | $92K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 34,213 | $91K |
| 86803 | <1% | 11,061 | $90K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,416 | $89K |
| 90697 | <1% | 4,051 | $89K | |
| 90716 | <1% | 5,123 | $88K | |
| 90707 | <1% | 5,061 | $85K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 3,376 | $85K |
| 99383 | <1% | 833 | $84K | |
| 84439 | <1% | 13,876 | $83K | |
| 73562 | <1% | 4,769 | $81K | |
| 82947 | <1% | 25,711 | $81K | |
| 93017 | <1% | 1,721 | $80K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 1,171 | $80K |
| 76813 | <1% | 1,058 | $80K | |
| 85610 | <1% | 27,190 | $73K | |
| 97166 | <1% | 772 | $73K | |
| P9016 | Red blood cells, leukocytes reduced, each unit | <1% | 232 | $71K |
| 92550 | <1% | 1,164 | $68K | |
| 90746 | <1% | 1,094 | $67K | |
| 83021 | <1% | 3,643 | $66K | |
| 82607 | <1% | 6,479 | $65K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 11,090 | $65K |
| 82728 | <1% | 6,445 | $65K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 13,792 | $65K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 227 | $63K |
| 95816 | <1% | 294 | $62K | |
| 92557 | <1% | 1,049 | $60K | |
| 86762 | <1% | 5,089 | $60K | |
| 70496 | <1% | 497 | $60K | |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | <1% | 64 | $60K |
| 83970 | <1% | 1,764 | $58K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 1,649 | $57K |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 718 | $57K |
| 92587 | <1% | 1,014 | $56K | |
| 94729 | <1% | 1,382 | $55K | |
| 10060 | <1% | 263 | $53K | |
| 36430 | <1% | 245 | $52K | |
| 90662 | <1% | 1,832 | $52K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 2,690 | $52K |
| 99384 | <1% | 568 | $52K | |
| 83880 | <1% | 3,463 | $47K | |
| 90633 | <1% | 8,747 | $45K | |
| 58300 | <1% | 423 | $43K | |
| 80076 | <1% | 5,334 | $43K | |
| 94760 | <1% | 22,189 | $43K | |
| 86765 | <1% | 3,706 | $42K | |
| J7300 | Intrauterine copper contraceptive (paragard) | <1% | 37 | $41K |
| Q3014 | Telehealth originating site facility fee | <1% | 3,502 | $41K |
| 84702 | <1% | 8,421 | $40K | |
| 84403 | <1% | 1,734 | $40K | |
| 73110 | <1% | 2,547 | $40K | |
| 87340 | <1% | 11,442 | $40K | |
| 87631 | <1% | 720 | $39K | |
| 90680 | <1% | 7,545 | $38K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 22,106 | $37K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 220 | $37K |
| 85018 | <1% | 2,120 | $37K | |
| 99381 | <1% | 391 | $37K | |
| 71045 | Radiologic examination, chest; single view | <1% | 12,402 | $37K |
| 84146 | <1% | 2,106 | $35K | |
| 73610 | <1% | 3,171 | $35K | |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 563 | $35K |
| 82570 | <1% | 9,122 | $35K | |
| 58301 | <1% | 315 | $35K | |
| 73130 | <1% | 2,978 | $35K | |
| 85027 | <1% | 20,728 | $34K | |
| 85730 | <1% | 22,708 | $34K | |
| 73630 | <1% | 3,276 | $34K | |
| 86706 | <1% | 4,512 | $34K | |
| 83001 | <1% | 2,027 | $33K | |
| 76775 | <1% | 758 | $33K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 2,905 | $32K |
| 73030 | <1% | 2,748 | $32K | |
| 84481 | <1% | 4,274 | $32K | |
| 82043 | <1% | 7,925 | $31K | |
| 82746 | <1% | 3,215 | $31K | |
| 90656 | <1% | 3,981 | $30K | |
| 0003A | <1% | 844 | $30K | |
| 0072A | <1% | 732 | $30K | |
| 0071A | <1% | 737 | $30K | |
| 57454 | <1% | 89 | $29K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 1,077 | $29K |
| 97116 | <1% | 1,071 | $28K | |
| 86580 | <1% | 2,162 | $28K | |
| 58100 | <1% | 126 | $28K | |
| 83002 | <1% | 1,735 | $28K | |
| 90734 | <1% | 5,996 | $28K | |
| 72100 | <1% | 2,000 | $27K | |
| 95811 | <1% | 45 | $27K | |
| 17110 | <1% | 177 | $26K | |
| 87070 | <1% | 5,150 | $25K | |
| 90648 | <1% | 5,113 | $25K | |
| 93925 | <1% | 133 | $25K | |
| 92567 | <1% | 811 | $24K | |
| 70491 | <1% | 169 | $24K | |
| 87077 | <1% | 4,363 | $24K | |
| 99382 | <1% | 243 | $23K | |
| 77061 | <1% | 463 | $23K | |
| 90698 | <1% | 5,587 | $22K | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | <1% | 51 | $22K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 9,773 | $22K |
| 70498 | <1% | 390 | $22K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 11,470 | $22K |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 676 | $21K |
| 77080 | <1% | 778 | $21K | |
| 86787 | <1% | 3,102 | $21K | |
| 92579 | <1% | 271 | $20K | |
| 76870 | <1% | 366 | $20K | |
| 92015 | Determination of refractive state | <1% | 398 | $20K |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 1,909 | $20K |
| 73140 | <1% | 1,505 | $20K | |
| 93923 | <1% | 258 | $20K | |
| 95806 | <1% | 268 | $19K | |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | <1% | 70 | $19K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 168 | $19K |
| 90674 | <1% | 1,343 | $19K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 3,155 | $19K |
| A0425 | Ground mileage, per statute mile | <1% | 2,605 | $19K |
| 86735 | <1% | 2,701 | $19K | |
| 97035 | <1% | 1,075 | $19K | |
| 83540 | <1% | 4,822 | $19K | |
| 11721 | <1% | 504 | $18K | |
| 97014 | <1% | 1,368 | $18K | |
| 0054A | <1% | 454 | $18K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 367 | $17K |
| 86704 | <1% | 2,375 | $17K | |
| 90714 | <1% | 710 | $17K | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 395 | $17K |
| 90739 | <1% | 142 | $17K | |
| 73080 | <1% | 1,545 | $16K | |
| 83550 | <1% | 4,187 | $16K | |
| 84153 | <1% | 2,261 | $16K | |
| 90710 | <1% | 3,557 | $16K | |
| 73502 | <1% | 979 | $16K | |
| 73590 | <1% | 1,835 | $16K | |
| 0124A | <1% | 399 | $16K | |
| 11981 | <1% | 79 | $15K | |
| 82627 | <1% | 803 | $15K | |
| 83525 | <1% | 1,437 | $15K | |
| 90723 | <1% | 3,570 | $15K | |
| 92552 | <1% | 214 | $15K | |
| 82803 | <1% | 1,238 | $15K | |
| 99201 | <1% | 219 | $15K | |
| 72110 | <1% | 496 | $14K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 76 | $14K |
| J2704 | Injection, propofol, 10 mg | <1% | 9,193 | $14K |
| 88307 | <1% | 132 | $14K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 8,819 | $14K |
| 76641 | <1% | 207 | $14K | |
| 82465 | <1% | 4,789 | $14K | |
| 90619 | <1% | 623 | $14K | |
| 95819 | <1% | 63 | $14K | |
| 84703 | <1% | 3,997 | $13K | |
| 84484 | <1% | 16,560 | $13K | |
| 98926 | <1% | 341 | $13K | |
| 85007 | <1% | 18,772 | $13K | |
| 90744 | <1% | 3,552 | $12K | |
| 87536 | <1% | 142 | $12K | |
| 88720 | <1% | 1,203 | $12K | |
| 74018 | <1% | 1,370 | $12K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 73 | $12K |
| 87186 | <1% | 3,712 | $12K | |
| 86695 | <1% | 1,116 | $11K | |
| 87081 | <1% | 2,027 | $11K | |
| 87338 | <1% | 1,540 | $11K | |
| 20610 | <1% | 81 | $11K | |
| 72040 | <1% | 776 | $11K | |
| 86376 | <1% | 941 | $11K | |
| 82950 | <1% | 2,751 | $10K | |
| 73700 | <1% | 71 | $10K | |
| 88312 | <1% | 783 | $10K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 13,325 | $10K |
| 97162 | <1% | 115 | $10K | |
| 90696 | <1% | 3,449 | $10K | |
| 94761 | <1% | 15,366 | $10K | |
| 94664 | <1% | 554 | $10K | |
| 76376 | <1% | 689 | $10K | |
| 83690 | <1% | 12,252 | $10K | |
| 90700 | <1% | 3,373 | $10K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 1,470 | $9K |
| 90653 | <1% | 277 | $9K | |
| 83921 | <1% | 529 | $9K | |
| 88304 | <1% | 454 | $9K | |
| 77062 | <1% | 177 | $9K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 395 | $8K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 3,390 | $8K |
| 99205 | Prolong outpt/office vis | <1% | 41 | $8K |
| 90681 | <1% | 2,678 | $8K | |
| 86708 | <1% | 1,021 | $8K | |
| 0052A | <1% | 189 | $8K | |
| 82247 | <1% | 2,227 | $8K | |
| C1769 | Guide wire | <1% | 179 | $7K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 11,436 | $7K |
| 94727 | <1% | 263 | $7K | |
| 82550 | <1% | 6,122 | $7K | |
| 82270 | <1% | 2,068 | $7K | |
| 86800 | <1% | 594 | $7K | |
| 84154 | <1% | 850 | $7K | |
| 73090 | <1% | 1,290 | $7K | |
| 86923 | <1% | 393 | $7K | |
| 86140 | <1% | 3,720 | $7K | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 6,812 | $6K |
| A0427 | Emergency ambulance ride, advanced life support | <1% | 115 | $6K |
| 82670 | <1% | 249 | $6K | |
| 72170 | <1% | 916 | $6K | |
| 86038 | <1% | 1,359 | $6K | |
| 0051A | <1% | 143 | $6K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 66 | $6K |
| 82784 | <1% | 559 | $6K | |
| 84480 | <1% | 1,153 | $6K | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 2,484 | $5K |
| 87040 | <1% | 3,727 | $5K | |
| 86403 | <1% | 1,408 | $5K | |
| 95117 | <1% | 284 | $5K | |
| 97167 | <1% | 26 | $5K | |
| 59025 | Fetal non-stress test | <1% | 50 | $5K |
| 93226 | <1% | 103 | $5K | |
| 80164 | <1% | 1,426 | $5K | |
| 76821 | <1% | 63 | $5K | |
| 92555 | <1% | 121 | $5K | |
| J1953 | Injection, levetiracetam, 10 mg | <1% | 546 | $5K |
| 84550 | <1% | 1,674 | $5K | |
| 84156 | <1% | 1,418 | $4K | |
| 80320 | <1% | 8,639 | $4K | |
| 83605 | <1% | 6,700 | $4K | |
| 83735 | <1% | 6,425 | $4K | |
| J7510 | Prednisolone oral, per 5 mg | <1% | 2,251 | $4K |
| 82150 | <1% | 2,652 | $4K | |
| 90647 | <1% | 1,255 | $4K | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 5,190 | $4K |
| 73552 | <1% | 530 | $4K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 4,052 | $4K |
| 71271 | <1% | 39 | $4K | |
| 86200 | <1% | 339 | $4K | |
| 84402 | <1% | 173 | $4K | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | <1% | 49 | $4K |
| 85651 | <1% | 3,347 | $4K | |
| 74022 | <1% | 732 | $4K | |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | <1% | 77 | $3K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 2,337 | $3K |
| 73560 | <1% | 111 | $3K | |
| 73060 | <1% | 633 | $3K | |
| 83516 | <1% | 381 | $3K | |
| 84100 | <1% | 4,781 | $3K | |
| 17250 | <1% | 30 | $3K | |
| 90713 | <1% | 531 | $3K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 4,023 | $3K |
| 93225 | <1% | 90 | $3K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 5,203 | $3K |
| 72141 | <1% | 13 | $3K | |
| 94375 | <1% | 541 | $3K | |
| 99401 | <1% | 63 | $3K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 12 | $3K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 4,533 | $3K |
| 82248 | <1% | 753 | $3K | |
| 98968 | <1% | 26 | $2K | |
| 81002 | <1% | 1,559 | $2K | |
| 87522 | Neg quan hep c or qual rna | <1% | 54 | $2K |
| 75574 | <1% | 12 | $2K | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | <1% | 556 | $2K |
| 97018 | <1% | 218 | $2K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 36 | $2K |
| 96376 | <1% | 1,630 | $2K | |
| 86360 | <1% | 55 | $2K | |
| 0081A | <1% | 71 | $2K | |
| 99406 | <1% | 115 | $2K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 3,244 | $2K |
| 95115 | <1% | 152 | $2K | |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 14 | $2K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 2,294 | $2K |
| 90846 | Family psychotherapy without the patient present, 50 minutes | <1% | 31 | $2K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 80 | $2K |
| 85044 | <1% | 1,640 | $2K | |
| 86480 | <1% | 38 | $2K | |
| 83615 | <1% | 837 | $2K | |
| 87177 | <1% | 254 | $2K | |
| 85379 | <1% | 1,468 | $2K | |
| 88313 | <1% | 251 | $2K | |
| 82951 | <1% | 299 | $2K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 62 | $2K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 17 | $2K |
| 99442 | <1% | 24 | $2K | |
| G0008 | Administration of influenza virus vaccine | <1% | 821 | $2K |
| 82274 | <1% | 282 | $2K | |
| 93308 | <1% | 14 | $2K | |
| 73620 | <1% | 88 | $2K | |
| 90688 | <1% | 203 | $2K | |
| 86431 | <1% | 509 | $2K | |
| 82553 | <1% | 2,193 | $2K | |
| J7042 | 5% dextrose/normal saline (500 ml = 1 unit) | <1% | 1,126 | $1K |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | <1% | 314 | $1K |
| 80069 | <1% | 190 | $1K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 837 | $1K |
| 86355 | <1% | 55 | $1K | |
| 91322 | <1% | 13 | $1K | |
| 82962 | <1% | 783 | $1K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 3,701 | $1K |
| 73523 | <1% | 67 | $1K | |
| 84132 | <1% | 324 | $1K | |
| J1815 | Injection, insulin, per 5 units | <1% | 3,070 | $1K |
| 80178 | <1% | 744 | $1K | |
| 96368 | <1% | 25 | $1K | |
| J1741 | Injection, ibuprofen, 100 mg | <1% | 173 | $1K |
| Q9957 | Injection, perflutren lipid microspheres, per ml | <1% | 24 | $1K |
| 91321 | <1% | 25 | $1K | |
| 86430 | <1% | 346 | $1K | |
| 71100 | <1% | 245 | $1K | |
| 97161 | <1% | 12 | $1K | |
| 82805 | <1% | 63 | $1K | |
| 86359 | <1% | 55 | $1K | |
| 72070 | <1% | 79 | $1K | |
| 92650 | <1% | 15 | $1K | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 674 | $1K |
| 86709 | <1% | 118 | $966.27 | |
| 88300 | <1% | 84 | $941.79 | |
| 73521 | <1% | 72 | $928.10 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 2,528 | $887.48 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 252 | $832.73 |
| 87045 | <1% | 175 | $830.46 | |
| 82977 | <1% | 199 | $803.92 | |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 85 | $798.08 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 900 | $796.09 |
| 0082A | <1% | 26 | $791.93 | |
| 72114 | <1% | 13 | $744.75 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 2,456 | $721.41 |
| 93307 | <1% | 13 | $677.63 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 465 | $640.94 |
| 81511 | <1% | 15 | $600.18 | |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 1,211 | $577.94 |
| 82010 | <1% | 1,258 | $560.11 | |
| 0013A | <1% | 14 | $524.00 | |
| 84165 | <1% | 84 | $466.86 | |
| 86592 | <1% | 550 | $450.92 | |
| 84145 | <1% | 638 | $423.47 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 2,160 | $421.97 |
| 82533 | <1% | 27 | $419.08 | |
| 93880 | <1% | 14 | $403.25 | |
| 80329 | <1% | 663 | $389.16 | |
| 87807 | <1% | 38 | $379.90 | |
| 86696 | <1% | 39 | $377.00 | |
| 85384 | <1% | 502 | $368.42 | |
| 86870 | <1% | 15 | $347.93 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 181 | $329.24 |
| 90661 | <1% | 147 | $305.90 | |
| 82397 | <1% | 36 | $303.91 | |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | <1% | 58 | $246.40 |
| 84144 | <1% | 16 | $236.71 | |
| 98960 | <1% | 12 | $224.49 | |
| J0295 | Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm | <1% | 218 | $219.95 |
| J1631 | Injection, haloperidol decanoate, per 50 mg | <1% | 88 | $214.96 |
| 90620 | <1% | 165 | $207.79 | |
| 97810 | <1% | 28 | $204.88 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 176 | $200.24 |
| 87205 | <1% | 84 | $168.70 | |
| 87209 | <1% | 24 | $166.56 | |
| 83520 | <1% | 15 | $154.09 | |
| 86703 | <1% | 12 | $152.51 | |
| 90685 | <1% | 288 | $144.94 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 63 | $143.26 |
| 87255 | <1% | 13 | $117.23 | |
| 87400 | <1% | 21 | $116.80 | |
| 82105 | <1% | 30 | $115.44 | |
| J0456 | Injection, azithromycin, 500 mg | <1% | 53 | $110.95 |
| 87339 | <1% | 107 | $108.52 | |
| G0009 | Administration of pneumococcal vaccine | <1% | 42 | $107.87 |
| 70360 | <1% | 12 | $101.50 | |
| J3411 | Injection, thiamine hcl, 100 mg | <1% | 302 | $88.47 |
| 73000 | <1% | 12 | $88.32 | |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 16 | $83.58 |
| 87075 | <1% | 57 | $72.91 | |
| J1940 | Injection, furosemide, up to 20 mg | <1% | 140 | $72.68 |
| 87206 | <1% | 14 | $71.61 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 116 | $68.68 |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | <1% | 1,216 | $57.66 |
| 87899 | <1% | 12 | $56.21 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 305 | $47.82 |
| 82375 | <1% | 92 | $35.55 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 12 | $23.24 |
| 83050 | <1% | 62 | $22.14 | |
| J1790 | Injection, droperidol, up to 5 mg | <1% | 54 | $6.80 |
| C1726 | Catheter, balloon dilatation, non-vascular | <1% | 46 | $1.68 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 15 | $0.00 |
| 99080 | 0% | 2,823 | $0.00 | |
| 99499 | 0% | 131 | $0.00 | |
| C1751 | Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) | 0% | 23 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDOSS, MOUNIR (CFO)
Parent organizationJAMAICA HOSPITAL
| Provider | Location | Paid |
|---|---|---|
| Flushing Hospital & Medical Center | Flushing, NY | $52.79M |
| Jamaica Hospital | Jamaica, NY | $37.88M |
| Jamaica Hospital | Jamaica, NY | $27.88M |
| Flushing Hospital & Medical Center | Flushing, NY | $18.18M |
| Advanced Center for Psychotherapy, INC. | Jamaica, NY | $15.08M |
| Jamaica Hospital Medical Center | Jamaica, NY | $1.42M |
| Medisys Ambulance Service INC | Jamaica, NY | $1.38M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.